251. Urea cycle disorder Clinical trials / Disease details
Clinical trials : 48 / Drugs : 52 - (DrugBank : 13) / Drug target genes : 4 - Drug target pathways : 29
Previous names | - | ||
---|---|---|---|
Other names | - | ||
Disease group | Metabolic diseases | ||
Related info (in Japanese) | - | ||
Specific pediatric chronic diseases, Japan (in Japanese) | 8-1-13. Ornitine transcarbamylase deficiency | ||
Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
251-1. | N-acetylglutamate synthase deficiency;NAGS deficiency; | 8-1-11. N-acetylglutamate synthetase deficiency | |
251-2. | Carbamoyl phosphate synthetase I deficiency;CPS1 deficiency; | 8-1-12. Carbamoylphosphate synthetase deficiency | |
251-3. | Ornithine transcarbamylase deficiency;OTC deficiency; | 8-1-13. Ornitine transcarbamylase deficiency | |
251-4. | Classic citrullinemia;Citrullinemia type I; | 8-1-14. Argininosuccinate synthetase deficiency; Citrullinaemia type 1 | |
251-5. | Argininosuccinic aciduria; | 8-1-15. Argininosuccinic aciduria | |
251-6. | Argininemia; | 8-1-16. Hyperarginemia | |
251-7. | Hiperornitinemia-hiperamonemia-homocitrulinuria syndrome;HHH syndrome; | 8-1-18. Hyperornithinemia |